Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study.
作者信息
Schneeweiss Maria C, Wyss Richard, Schneeweiss Sebastian, Anand Priyanka, Jin Yinzhu, Dicesare Elyse, Glynn Robert J, Merola Joseph F
机构信息
Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
出版信息
J Am Acad Dermatol. 2024 Jan;90(1):134-137. doi: 10.1016/j.jaad.2023.08.025. Epub 2023 Aug 19.
Abstract
摘要
相似文献
1
Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study.接受度普利尤单抗治疗的特应性皮炎患者的关节疼痛：一项美国全国性队列研究。
J Am Acad Dermatol. 2024 Jan;90(1):134-137. doi: 10.1016/j.jaad.2023.08.025. Epub 2023 Aug 19.
2
Dupilumab alleviates pruritus regardless of skin improvement in adults with atopic dermatitis: A cohort study.度普利尤单抗可缓解成人特应性皮炎患者的瘙痒，无论皮肤是否改善：一项队列研究。
J Am Acad Dermatol. 2024 Jan;90(1):195-196. doi: 10.1016/j.jaad.2023.09.043. Epub 2023 Sep 24.
3
Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: A nationwide US study.美国一项全国性研究：特应性皮炎孕妇使用全身性免疫调节药物的情况。
J Am Acad Dermatol. 2023 Jul;89(1):178-181. doi: 10.1016/j.jaad.2023.02.047. Epub 2023 Mar 10.
4
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.在一项开放性研究中，度普利尤单抗为中重度特应性皮炎成人患者提供了长达 4 年的可接受安全性和持续疗效。
Am J Clin Dermatol. 2022 May;23(3):393-408. doi: 10.1007/s40257-022-00685-0. Epub 2022 May 3.
5
Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab.特应性皮炎控制工具在接受度普利尤单抗治疗的中重度特应性皮炎患者长期监测中的新作用
Dermatitis. 2024 Jan-Feb;35(S1):S107-S108. doi: 10.1089/derm.2023.0052. Epub 2023 Aug 18.
6
An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab.一项关于从度普利尤单抗转换治疗后使用阿布昔替尼治疗中度至重度特应性皮炎成人患者的观察性研究。
J Am Acad Dermatol. 2023 Oct;89(4):826-828. doi: 10.1016/j.jaad.2023.05.077. Epub 2023 Jun 10.
7
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis.地氯雷他定联合糠酸莫米松治疗 6 月龄至 5 岁中重度特应性皮炎儿童的疗效和安全性。
Adv Ther. 2024 Mar;41(3):1046-1061. doi: 10.1007/s12325-023-02753-1. Epub 2024 Jan 9.
8
Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network.比较度普利尤单抗和常规全身治疗治疗特应性皮炎患者的安全性特征：来自美国网络的真实世界数据。
J Dermatolog Treat. 2024 Dec;35(1):2421429. doi: 10.1080/09546634.2024.2421429. Epub 2024 Nov 3.
9
Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials.使用度普利尤单抗治疗的中度至重度特应性皮炎成年患者最佳瘙痒反应的起效和长期维持：两项3期试验的事后分析
Adv Ther. 2025 Apr;42(4):1800-1810. doi: 10.1007/s12325-025-03124-8. Epub 2025 Feb 19.
10
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study.度普利尤单抗治疗 6 个月至 5 岁中重度特应性皮炎患儿 1 年的安全性和疗效：一项开放标签扩展研究的结果。
Am J Clin Dermatol. 2024 Jul;25(4):655-668. doi: 10.1007/s40257-024-00859-y. Epub 2024 May 14.
引用本文的文献
1
Adverse effects of biologics used to treat asthma.用于治疗哮喘的生物制剂的不良反应。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251319175. doi: 10.1177/17534666251319175. Epub 2025 Mar 18.
2
The Rare Adverse Effect of Myalgia After Dupilumab Biologic Therapy for Refractory Atopic Dermatitis.度普利尤单抗生物疗法治疗难治性特应性皮炎后出现肌痛这一罕见不良反应。
Cureus. 2024 May 20;16(5):e60701. doi: 10.7759/cureus.60701. eCollection 2024 May.
3
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.OX40 在特应性皮炎发病机制中的作用——一个新的治疗靶点。
Am J Clin Dermatol. 2024 May;25(3):447-461. doi: 10.1007/s40257-023-00838-9. Epub 2024 Jan 18.
Zotero 插件